当前位置:首页 - 行情中心 - 光正眼科(002524) - 财务分析 - 利润表

光正眼科

(002524)

  

流通市值:19.66亿  总市值:19.89亿
流通股本:5.09亿   总股本:5.15亿

利润表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、营业总收入390,144,820.93187,042,350.77885,181,180.03663,491,611.66
  营业收入390,144,820.93187,042,350.77885,181,180.03663,491,611.66
二、营业总成本386,767,624.74190,984,978.41892,198,398.94669,323,200.43
  营业成本234,572,862.1113,946,921.54563,817,392.43421,943,003.8
  税金及附加2,218,918.821,403,381.434,748,093.273,929,157.63
  销售费用79,795,404.1339,351,023.52170,314,597.04128,148,259.64
  管理费用53,558,857.2127,746,462.23114,176,666.1286,766,589.09
  研发费用750,006375,0074,128,1031,875,002
  财务费用15,871,576.488,162,182.6935,013,547.0826,661,188.27
  其中:利息费用15,180,457.947,801,151.5433,960,876.8625,958,366.96
  其中:利息收入80,601.643,669.38459,882.38420,348.59
三、其他经营收益
  加:投资收益20,500,823.63-150,661.759,519,546.879,522,973.17
  资产处置收益1,488,263.24--204,958.49653,964.74
  资产减值损失(新)833,414.79765,233.18-4,833,829.3104,514.06
  信用减值损失(新)-792,727.79984,874.383,189,294.832,130,730.66
  其他收益2,229,260.341,586,875.93,664,267.381,178,282.67
四、营业利润27,636,230.4-756,305.934,317,102.387,758,876.53
  加:营业外收入92,186.54135,091.251,273,040.881,341,606.32
  减:营业外支出3,307,368.96351,255.417,247,026.763,949,062.69
五、利润总额24,421,047.98-972,470.09-1,656,883.55,151,420.16
  减:所得税费用6,628,862.82,869,985.2518,014,265.534,771,413.72
六、净利润17,792,185.18-3,842,455.34-19,671,149.03380,006.44
(一)按经营持续性分类
  持续经营净利润17,792,185.18-3,842,455.34-19,671,149.03380,006.44
(二)按所有权归属分类
  归属于母公司股东的净利润17,775,783.47-3,835,314.58-19,497,356.96173,418.14
  少数股东损益16,401.71-7,140.76-173,792.07206,588.3
  扣除非经常损益后的净利润-3,231,677.73-4,796,464.34-28,053,860.95-9,175,309.61
七、每股收益
  (一)基本每股收益0.03-0.01-0.040
  (二)稀释每股收益0.03-0.01-0.040
九、综合收益总额17,792,185.18-3,842,455.34-19,671,149.03380,006.44
  归属于母公司股东的综合收益总额17,775,783.47-3,835,314.58-19,497,356.96173,418.14
  归属于少数股东的综合收益总额16,401.71-7,140.76-173,792.07206,588.3
公告日期2026-08-222026-04-282026-04-242025-10-24
审计意见(境内)标准无保留意见
TOP↑